Activity in this selectionOct 5, 2026 · Jan 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $5.7M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionAurenarDeveloper of a non-invasive, single-use neuromodulation platform to reduce life-threatening complications in ICU patients.
Role not disclosed